Celanese Corp.

Chemicals
United States
Earnings Per Share Growth (%)-50%
Cost of Goods Sold (US$ Millions)$4,356
Current Liabilities (US$ Millions)$1,550
Total Assets (US$ Millions)$2,787
Long Term Debt$2,468
Return on Equity10.79%
Revenue (US$ Millions)$5,674
Total Company Assets$8,586
Revenue Growth (%)-16.58%
Net Income (US$ Millions)$304
Earnings Per Share (US$)($50)
Total Equity (US$ Millions)$2,378
Profit Margin (%)5.36%
Debt To Equity Ratio (%)1.04%
Inventory Turnover$682